Effect of high-dose dexamethasone on perioperative lactate levels and glucose control: a randomized controlled trial

详细信息    查看全文

• 作者：Thomas H Ottens (1)
  Maarten WN Nijsten (2)
  Jan Hofland (3)
  Jan M Dieleman (1)
  Miriam Hoekstra (4)
  Diederik van Dijk (1)
  Joost MAA van der Maaten (2) (4)
  
  1. Department of Anesthesiology and Intensive Care ; University Medical Center Utrecht ; Mail stop Q.04.2.313 ; PO Box 85500 ; Utrecht ; 3508 ; GA ; The Netherlands
  2. Department of Critical Care ; University Medical Center ; University of Groningen ; Hanzeplein 1 ; Groningen ; RB ; 9700 ; The Netherlands
  3. Department of Anesthesiology ; Erasmus University Medical Center ; 鈥檚 Gravendijkwal 230 ; Rotterdam ; CE ; 3015 ; The Netherlands
  4. Department of Anesthesiology ; University Medical Center Groningen ; University of Groningen ; Hanzeplein 1 ; Groningen ; RB ; 9700 ; The Netherlands
  
• 刊名：Critical Care
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：19
• 期：1
• 全文大小：717 KB
• 参考文献：1. Dieleman, JM, Paassen, J, Dijk, D, Arbous, MS, Kalkman, CJ, Vandenbroucke, JP (2011) Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev. 5: pp. CD005566
  2. Whitlock, RP, Chan, S, Devereaux, PJ, Sun, J, Rubens, FD, Thorlund, K (2008) Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J. 29: pp. 2592-600 CrossRef
  3. Dieleman, JM, Nierich, AP, Rosseel, PM, Maaten, JM, Hofland, J, Diephuis, JC (2012) Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 308: pp. 1761-7 4144" target="_blank" title="It opens in new window">CrossRef
  4. Cappabianca, G, Rotunno, C, Luca Tupputi Schinosa, L, Ranieri, VM, Paparella, D (2011) Protective Effects of Steroids in Cardiac Surgery: A Meta-Analysis of Randomized Double-Blind Trials. J Cardiothorac Vasc Anesth 25: pp. 156-65 CrossRef
  5. Berghe, G, Wouters, P, Weekers, F, Verwaest, C, Bruyninckx, F, Schetz, M (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med. 345: pp. 1359-67 CrossRef
  6. Finfer, S, Chittock, DR, Su, SY, Blair, D, Foster, D (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: pp. 1283-97 CrossRef
  7. Kilger, E, Weis, F, Briegel, J, Frey, L, Goetz, AE, Reuter, D (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med. 31: pp. 1068-74 46.89546.98" target="_blank" title="It opens in new window">CrossRef
  8. Mayumi, H, Zhang, QW, Nakashima, A, Masuda, M, Kohno, H, Kawachi, Y (1997) Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg. 63: pp. 129-37 4975(96)00682-0" target="_blank" title="It opens in new window">CrossRef
  9. Taylor, DJ, Faragher, EB, Evanson, JM (1992) Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. Circ Shock. 37: pp. 105-10
  10. Wurtman, RJ, Axelrod, J (1966) Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem 25: pp. 2301-5
  11. Luchette, FA, Friend, LA, Brown, CC, Upputuri, RK, James, JH (1998) Increased skeletal muscle Na+, K鈥?鈥?ATPase activity as a cause of increased lactate production after hemorrhagic shock. J Trauma. 44: pp. 796-803 CrossRef
  12. Landow, L (1993) Splanchnic lactate production in cardiac surgery patients. Crit Care Med. 21: pp. S84-91 46-199302001-00015" target="_blank" title="It opens in new window">CrossRef
  13. Maerz, LL, Akhtar, S (2011) Perioperative glycemic management in 2011: paradigm shifts. Curr Opin Crit Care. 17: pp. 370-5
  14. Akhtar, S, Barash, PG, Inzucchi, SE (2010) Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. 110: pp. 478-97 CrossRef
  15. Bakker, J, Nijsten, M, Jansen, TC (2013) Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care. 10: pp. 12 CrossRef
  16. Maillet, J-M, Besnerais, P, Cantoni, M, Nataf, P, Ruffenach, A, Lessana, A (2003) Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest. 123: pp. 1361-6 CrossRef
  17. Abramson, D, Scalea, TM, Hitchcock, R, Trooskin, SZ, Henry, SM, Greenspan, J (1993) Lactate clearance and survival following injury. J Trauma. 35: pp. 584-9 4" target="_blank" title="It opens in new window">CrossRef
  18. Bakker, J, Gris, P, Coffernils, M, Kahn, RJ, Vincent, JL (1996) Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 171: pp. 221-6 CrossRef
  19. Jansen, TC, Bommel, J, Woodward, R, Mulder, PG, Bakker, J (2009) Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study. Crit Care Med. 37: pp. 2369-74 CrossRef
  20. McNelis, J, Marini, C, Jurkiewicz, A, Szomstein, S, Simms, H, Ritter, G (2001) Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg. 182: pp. 481-5 CrossRef
  21. Vogelzang, M, Zijlstra, F, Nijsten, MW (2005) Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak. 5: pp. 38 472-6947-5-38" target="_blank" title="It opens in new window">CrossRef
  22. Vogelzang, M, Loef, BG, Regtien, JG, Horst, IC, Assen, H, Zijlstra, F (2008) Computer-assisted glucose control in critically ill patients. Intensive Care Med. 34: pp. 1421-7 4-008-1091-y" target="_blank" title="It opens in new window">CrossRef
  23. Vogelzang, M, Horst, IC, Nijsten, MW (2004) Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 8: pp. R122-7 40" target="_blank" title="It opens in new window">CrossRef
  24. Nashef, SA, Roques, F, Michel, P, Gauducheau, E, Lemeshow, S, Salamon, R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 16: pp. 9-13 40(99)00134-7" target="_blank" title="It opens in new window">CrossRef
  25. Jansen, TC, Bommel, J, Schoonderbeek, FJ, Visser, SJ, Klooster, JM, Lima, AP (2010) Early Lactate-Guided Therapy in Intensive Care Unit Patients. Am J Respir Crit Care Med. 182: pp. 752-61 4/rccm.200912-1918OC" target="_blank" title="It opens in new window">CrossRef
  26. Annane, D, Bellissant, E, Bollaert, P-E, Briegel, J, Confalonieri, M, Gaudio, R (2009) Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 301: pp. 2362-75 CrossRef
  27. El-Azab, SR (2002) Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesthesia. 88: pp. 496-501 4.496" target="_blank" title="It opens in new window">CrossRef
  28. Jansen, NJ, Oeveren, W, Broek, L, Oudemans-Van Straate, HM, Stoutenbeek, CP, Joen, MC (1991) Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 102: pp. 515-25
  29. Karaman, K, Bostanci, EB, Aksoy, E, Ulas, M, Yigit, T, Erdemli, MO (2013) Effects of dexamethasone and pheniramine hydrogen maleate on stress response in patients undergoing elective laparoscopic cholecystectomy. Am J Surg. 205: pp. 213-9 CrossRef
  30. Kilger, E, Weis, FC, Goetz, AE, Frey, L, Kesel, K, Sch眉tz, A (2001) Intensive care after minimally invasive and conventional coronary surgery: a prospective comparison. Intensive Care Med. 27: pp. 534-9 40000788" target="_blank" title="It opens in new window">CrossRef
  31. Harris, DN, Bailey, SM, Smith, PL, Taylor, KM, Oatridge, A, Bydder, GM (1993) Brain swelling in first hour after coronary artery bypass surgery. Lancet. 342: pp. 586-7 40-6736(93)91412-F" target="_blank" title="It opens in new window">CrossRef
  32. Kaukonen, K-M, Bailey, M, Egi, M, Orford, N, Glassford, NJ, Marik, PE (2014) Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study. Crit Care Med. 42: pp. 1379-85 4" target="_blank" title="It opens in new window">CrossRef
  
• 刊物主题：Intensive / Critical Care Medicine; Emergency Medicine;
• 出版者：BioMed Central
• ISSN：1364-8535

文摘

Introduction Blood lactate levels are increasingly used to monitor patients. Steroids are frequently administered to critically ill patients. However, the effect of steroids on lactate levels has not been adequately investigated. We studied the effect of a single intraoperative high dose of dexamethasone on lactate and glucose levels in patients undergoing cardiac surgery. Methods The Dexamethasone for Cardiac Surgery (DECS) trial was a multicenter randomized trial on the effect of dexamethasone 1聽mg/kg versus placebo on clinical outcomes after cardiac surgery in adults. Here we report a pre-planned secondary analysis of data from DECS trial participants included at the University Medical Center Groningen. The use of a computer-assisted glucose regulation protocol鈥擥lucose Regulation for Intensive care Patients (GRIP)鈥攚as part of routine postoperative care. GRIP aimed at glucose levels of 4 to 8聽mmol/L. Primary outcome parameters were area under the lactate and glucose curves over the first 15聽hours of ICU stay (AUC15). ICU length of stay and mortality were observed as well. Results The primary outcome could be determined in 497 patients of the 500 included patients. During the first 15聽hours of ICU stay, lactate and glucose levels were significantly higher in the dexamethasone group than in the placebo group: lactate AUC15 25.8 (13.1) versus 19.9 (11.2) mmol/L鈥壝椻€塰our, P 15 126.5 (13.0) versus 114.4 (13.9) mmol/L鈥壝椻€塰our, P P鈥?鈥?.001), and 30-day mortality rates were 1.6% and 2.4%, respectively (P鈥?鈥?.759). Conclusions Intraoperative high-dose dexamethasone increased postoperative lactate and glucose levels in the first 15聽hours of ICU stay. Still, patients in the dexamethasone group had a shorter ICU length of stay and similar mortality compared with controls. Trial registration ClinicalTrials.gov NCT00293592. Registered 16 February 2006.